Literature DB >> 5839398

Metabolism of chloroquine and hydroxychloroquine in albino and pigmented rats.

E W McChesney, W F Banks, D J Sullivan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1965        PMID： 5839398     DOI： 10.1016/0041-008x(65)90050-5

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN： 0041-008X            Impact factor:   4.219


× No keyword cloud information.
  9 in total

1.  Cardiac Complications Attributed to Chloroquine and Hydroxychloroquine: A Systematic Review of the Literature.

Authors:  Clotilde Chatre; François Roubille; Hélène Vernhet; Christian Jorgensen; Yves-Marie Pers
Journal:  Drug Saf       Date:  2018-10       Impact factor: 5.606

2.  Long-term use of hydroxychloroquine reduces antiphospholipid antibodies levels in patients with primary antiphospholipid syndrome.

Authors:  Entela Nuri; Mara Taraborelli; Laura Andreoli; Marta Tonello; Maria Gerosa; Antonia Calligaro; Lorenza Maria Argolini; Rajesh Kumar; Vittorio Pengo; Pier Luigi Meroni; Amelia Ruffatti; Angela Tincani
Journal:  Immunol Res       Date:  2017-02       Impact factor: 2.829

3.  Ocular effects of chlorpromazine and oxypertine on beagle dogs.

Authors:  J Legros; I Rosner; C Berger
Journal:  Br J Ophthalmol       Date:  1971-06       Impact factor: 4.638

4.  Chloroquine disposition in hypersensitive and non-hypersensitive subjects and its significance in chloroquine-induced pruritus.

Authors:  E E Essien; E I Ette; W O Thomas; E A Brown-Awala
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1989 Jan-Mar       Impact factor: 2.441

5.  Physiologically Based Pharmacokinetics of Lysosomotropic Chloroquine in Rat and Human.

Authors:  Xin Liu; William J Jusko
Journal:  J Pharmacol Exp Ther       Date:  2020-12-04       Impact factor: 4.030

Review 6.  Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases.

Authors:  K D Rainsford; Ann L Parke; Matthew Clifford-Rashotte; W F Kean
Journal:  Inflammopharmacology       Date:  2015-08-06       Impact factor: 5.093

7.  A chloroquine-induced macrophage-preconditioning strategy for improved nanodelivery.

Authors:  Joy Wolfram; Sara Nizzero; Haoran Liu; Feng Li; Guodong Zhang; Zheng Li; Haifa Shen; Elvin Blanco; Mauro Ferrari
Journal:  Sci Rep       Date:  2017-10-23       Impact factor: 4.379

8.  Quantitative Fundus Autofluorescence in Systemic Chloroquine/Hydroxychloroquine Therapy.

Authors:  Clara Reichel; Andreas Berlin; Victoria Radun; Ioana-Sandra Tarau; Jost Hillenkamp; Nikolai Kleefeldt; Kenneth R Sloan; Thomas Ach
Journal:  Transl Vis Sci Technol       Date:  2020-08-28       Impact factor: 3.283

9.  How Could In Vitro Antiviral Activity Be Applied to Optimize the Dosing Regimens of Candidates for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)?

Authors:  Ranran Jia; Hongyun Wang
Journal:  Clin Infect Dis       Date:  2021-07-15       Impact factor: 9.079
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.